AbbVie
ABBV
#25
Rank
C$521.67 B
Marketcap
$294.90
Share price
-1.55%
Change (1 day)
20.19%
Change (1 year)

The biotechnology and pharmaceutical company Abbvie, spelled AbbVie, was founded in 2013 as a spin-off from Abbott Laboratories and is traded on the NYSE stock exchange in the S&P 100 index under the symbol โ€œABBVโ€.

AbbVie (ABBV) - Total assets

Total assets on the balance sheet as of December 2024 : C$193.23 Billion

According to AbbVie's latest financial reports the company's total assets are C$193.23 Billion. A companyโ€™s total assets is the sum of all current and non-current assets, such as inventories, cash and cash equivalents, properties and equipment.

AbbVie - Total assets on balance sheet (from 2011 to 2024)

Total assets by year

Year Total assets Change
2024-12-31C$193.95 B8.55%
2023-12-31C$178.67 B-5.14%
2022-12-31C$188.35 B0.86%
2021-12-31C$186.74 B-2.73%
2020-12-31C$191.98 B64.95%
2019-12-31C$116.38 B43.96%
2018-12-31C$80.84 B-9.15%
2017-12-31C$88.99 B0.19%
2016-12-31C$88.82 B20.7%
2015-12-31C$73.59 B130.49%
2014-12-31C$31.92 B2.73%
2013-12-31C$31.08 B15.73%
2012-12-31C$26.85 B35.25%
2011-12-31C$19.85 B-6.01%
2010-12-31C$21.12 B

Total Assets for similar companies or competitors

Company Total assets differencediff. Country
C$305.09 B 57.88%๐Ÿ‡บ๐Ÿ‡ธ USA
C$132.39 B-31.49%๐Ÿ‡บ๐Ÿ‡ธ USA
C$112.53 B-41.76%๐Ÿ‡บ๐Ÿ‡ธ USA
C$131.30 B-32.05%๐Ÿ‡บ๐Ÿ‡ธ USA
C$84.34 B-56.35%๐Ÿ‡บ๐Ÿ‡ธ USA
C$40.10 B-79.25%๐Ÿ‡บ๐Ÿ‡ธ USA
C$106.68 B-44.79%๐Ÿ‡ฌ๐Ÿ‡ง UK
C$148.73 B-23.03%๐Ÿ‡ฌ๐Ÿ‡ง UK
C$5.31 B-97.25%๐Ÿ‡บ๐Ÿ‡ธ USA